logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Pelvic Inflammatory Disease

    FiltersReset Filters
    18 results

    • azithromycin

      (AZITHROMYCIN MONOHYDRATE)
      Fresenius Kabi USA, LLC
      Usage: Azithromycin for injection is indicated for treating infections from specific susceptible bacteria, including community-acquired pneumonia and pelvic inflammatory disease, in patients needing initial intravenous therapy. It should be used judiciously to avoid drug-resistant bacteria and may be followed by oral Azithromycin as needed.

    • azithromycin

      (azithromycin monohydrate)
      Sagent Pharmaceuticals
      Usage: Azithromycin for injection is indicated for treating infections from susceptible microorganisms, such as community-acquired pneumonia and pelvic inflammatory disease, requiring initial intravenous therapy. It should be used judiciously to combat drug-resistant bacteria, with consideration of culture data when available.

    • ceftriaxone

      (Ceftriaxone)
      Xellia Pharmaceuticals USA LLC
      Usage: Ceftriaxone for Injection is indicated for treating infections caused by susceptible bacteria, including lower respiratory tract infections, acute otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, septicemia, bone and joint infections, intra-abdominal infections, meningitis, and for surgical prophylaxis.

    • ceftriaxone

      (Ceftriaxone)
      WG Critical Care, LLC
      Usage: Ceftriaxone for Injection is indicated for treating various infections caused by susceptible bacteria, including lower respiratory tract infections, acute bacterial otitis media, skin infections, urinary tract infections, uncomplicated gonorrhea, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, intra-abdominal infections, meningitis, and for surgical prophylaxis.

    • ceftriaxone sodium

      (Ceftriaxone Sodium)
      Hospira, Inc
      Usage: Ceftriaxone for injection is indicated for treating various infections, including lower respiratory tract infections, acute bacterial otitis media, skin infections, urinary tract infections, gonorrhea, pelvic inflammatory disease, bacterial septicemia, bone and joint infections, intra-abdominal infections, meningitis, and for surgical prophylaxis in at-risk patients.

    • clindamycin hydrochloride

      (Clindamycin hydrochloride)
      Micro Labs Limited
      Usage: Clindamycin is indicated for treating serious infections caused by susceptible anaerobic bacteria, streptococci, pneumococci, and staphylococci. It is often reserved for penicillin-allergic patients or when penicillin is inappropriate. Conditions include respiratory, skin, soft tissue, intra-abdominal, and female pelvic infections. Bacteriologic studies are recommended.

    • ertapenem

      (ertapenem sodium)
      Hikma Pharmaceuticals USA Inc.
      Usage: Ertapenem for injection is indicated for various infections in adults and pediatric patients (3 months and older), including complicated intra-abdominal, skin and skin structure infections, community-acquired pneumonia, complicated urinary tract infections, acute pelvic infections, and for prophylaxis of surgical site infections following elective colorectal surgery.

    • ertapenem

      (ertapenem sodium)
      Qilu Antibiotics Pharmaceutical Co., Ltd.
      Usage: Ertapenem is indicated for treating complicated intra-abdominal, skin and skin structure, community-acquired pneumonia, complicated urinary tract infections, acute pelvic infections, and for prophylaxis of surgical site infections after elective colorectal surgery in patients aged 3 months and older, targeting specific susceptible bacteria.

    • ertapenem

      (ertapenem)
      WG Critical Care, LLC
      Usage: Ertapenem for Injection is indicated for the treatment of various infections in adult and pediatric patients (3 months and older), including complicated intra-abdominal, skin, and urinary tract infections, community-acquired pneumonia, acute pelvic infections, and for prophylaxis of surgical site infections following elective colorectal surgery.

    • ertapenem

      (Ertapenem)
      Eugia US LLC
      Usage: Ertapenem for injection is indicated for treating complicated intra-abdominal, skin, skin structure, community-acquired pneumonia, urinary tract infections, acute pelvic infections, and for prophylaxis of surgical site infections after elective colorectal surgery in patients aged 3 months and older.